The Patent Finder

Altavant Sciences GmbH

Also on record
Records under this name other than the patents Altavant Sciences GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.

Back to Altavant Sciences GmbH

PatentTitleStatus Expires Confidence
US 11,718,853Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,940,683Localized Therapy of Lower Airways Inflammatory Disorders with Proinflammatory Cytokine Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,413,287Method for Treating Pulmonary Arterial Hypertension and Associated Pulmonary Arterial Hypertension
Lapsed on the fee record
Ended Aug 16, 2026 · High confidence
Lapsed on the fee recordEnded Aug 16, 2026High confidence
US 10,045,988Spirocyclic Compounds as Tryptophan Hydroxylase Inhibitors
Lapsed on the fee record
Ended Aug 14, 2026 · High confidence
Lapsed on the fee recordEnded Aug 14, 2026High confidence
US 8,637,469Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors
Lapsed on the fee record
Ended Jan 28, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jan 28, 2026From the USPTO record
US 11,203,597Crystalline spirocyclic compound, a dosage form containing, a method for using in treatment of disease, and a method for recrystallizing
Lapsed on the fee record
Ended Dec 21, 2025 · From the USPTO record
Lapsed on the fee recordEnded Dec 21, 2025From the USPTO record
US 9,750,740Spirocyclic Compounds as Tryptophan Hydroxylase Inhibitors
Lapsed on the fee record
Ended Sep 5, 2025 · High confidence
Lapsed on the fee recordEnded Sep 5, 2025High confidence
US 11,091,763Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
Lapsed on the fee record
Ended Aug 17, 2025 · From the USPTO record
Lapsed on the fee recordEnded Aug 17, 2025From the USPTO record
US 9,611,201Processes for preparing (R)-1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanone
Lapsed on the fee record
Ended Apr 4, 2025 · From the USPTO record
Lapsed on the fee recordEnded Apr 4, 2025From the USPTO record
US 10,946,018Spirocyclic Compounds as Tryptophan Hydroxylase Inhibitors
Lapsed on the fee record
Ended Mar 16, 2025 · High confidence
Lapsed on the fee recordEnded Mar 16, 2025High confidence
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited